| Name | Title | Contact Details |
|---|
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.
QSpex embodies the ideal to provide its capital partners best-in-class financial returns, and its customers distinguishable and meaningful value. We will deliver on these fundamentals, while delivering on a higher purpose, advancing the eco-system at-large. We will do this through an inspired vision, integrated ideals, an accountable organization and compassionate leadership.
ASG - Aids/HIV Servcies Group is a Charlottesville, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Patheous Health is a company that specializes in dysphagia healthcare and swallowing impairment conditions. They offer an Integrated Dysphagia Healthcare (iDH) platform and provide service solutions for both MBS and FEES studies.
Sunyard is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.